Hantz Financial Services, Inc. Bio Rad Laboratories, Inc. Transaction History

Hantz Financial Services, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Aug 06, 2024	SELL	$350.25 - $422.63 $1,401 - $1,690	-4 Reduced 11.76%	30 $11,000
Q1 2023 Aug 06, 2024	SELL	$418.69 - $503.0 $8,792 - $10,563	-21 Reduced 38.18%	34 $16,000
Q4 2022 Aug 06, 2024	BUY	$351.71 - $456.01 $18,288 - $23,712	52 Added 1733.33%	55 $23,000
Q2 2021 Aug 06, 2024	SELL	$576.64 - $649.04 $70,926 - $79,831	-123 Reduced 97.62%	3 $2,000
Q1 2021 Aug 06, 2024	BUY	$547.01 - $662.35 $68,923 - $83,456	126 New	126 $72,000
Q4 2020 Aug 06, 2024	SELL	$510.68 - $643.45 $24,512 - $30,885	-48 Reduced 26.09%	136 $79,000
Q3 2020 Aug 06, 2024	SELL	$454.43 - $535.6 $9,997 - $11,783	-22 Reduced 10.68%	184 $95,000
Q2 2020 Aug 06, 2024	SELL	$334.87 - $493.06 $37,840 - $55,715	-113 Reduced 35.42%	206 $93,000
Q1 2020 Aug 06, 2024	BUY	$320.01 - $409.07 $102,083 - $130,493	319 New	319 $112,000

478

19.2M

15.7K

11.5K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $6.43B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Hantz Financial Services, Inc., based on Form 13F filings with the SEC.

Stay updated on Hantz Financial Services, Inc. with notifications on news.